AIM:
Total number of AIM Companies (Incl Susp):
878*
Total number of AIM Companies trading:
796*
*as at close of business 30 September 2019
Standard List** of Main Market:
Total number of Standard List Companies
(Incl Susp):
165*
Total number of Standard List Companies trading:
143*
*as at close of business 30 September 2019
NEX Growth Market:
Total number of NEX Growth Market Companies (Incl Susp):
88*
Total number of NEX Growth Market Companies trading:
86*
*as at close of business 30 September 2019
*A corporate client of Hybridan LLP
** Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity
Dish of the day
Entertainment AI (LON:EAI) - This was an RTO into Blockchain Worldwide (BLOC), It has also transferred from the standard list to AIM. Focused on providing its global automotive and lifestyle audiences and its strategic partner audiences with real-time access, in a frictionless way, to "in the moment" opportunities from more relevant short form video content to "one-click" e-commerce, £8.6m raised. H1 2019 actuals - GTChannel subsidiary's MCN gross advertising revenue at $8.7 m, up 107%
Off the menu
Goals Soccer Centres has left AIM.
What’s cooking in the IPO kitchen?
Main Market Standard
Kaspi.kz, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services. GDR offering expected Oct 2019. In the first half of 2019, the Company generated total revenue of KZT226,862m (U.S. $598m), up 34% and net income of KZT77,001m (U.S. $203m), up 54%
Main Market premium
Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators in five African growth economies. Revenue increased 7 per cent. year-on-year to
Banquet Buffet
Altitude Group (LON:ALT) 53.4p £36.7m
Altitude Group, the operator of a leading marketplace for personalised products, announces its unaudited results for the six months ended 30 June 2019.
Highlights
Revenue growth of 43% to £5.4m (H1 2018: £3.8m)
Gross profit up 78% to £3.7m (H1 2018: £2.1m)
Adjusted operating profit* of £0.3m (H1 2018 loss: £0.3m)
Loss before taxation £0.9m (H1 2018 loss: £0.7m)
Successful integration of the AI Mastermind business acquired in January 2019, renamed AIM Smarter LLC
Accelerated US hiring and training process complete across all divisions; sales, marketing, technology, customer service and accounting
AIM membership and aggregate member annual revenues increased by 14% to 2,185 and 12% to circa $2.1 billion respectively since acquisition
161 suppliers now signed up to our Preferred Supplier Program
92 members upgraded to enhanced services
mporium Group (LON:MPM) 0.5p £5.2m
Mporium Group, the technology firm delivering event-driven marketing, announced that it has entered into non-binding heads of terms for the acquisition of the entire issued share capitals of Click Laboratories Limited and We Breathe Media Ltd, two companies under substantially common ownership operating a performance-based digital agency focused on the design, build and delivery of end-to-end multi-channel lead generation campaigns, for a maximum consideration of £5.5m.
Highlights
Click Labs specialises in email-marketing as well as providing critical technology, tools and know-how to optimise lead generation performance which is highly complementary to Mporium's expertise in search, social and display marketing
Potential Acquisition expected to make a material positive contribution to the Group's performance in FY2019 and onwards, and is expected to accelerate Mporium's pathway to becoming net cash generative
The initial cash consideration and Potential Acquisition and ongoing working capital needs of the Group are proposed to be financed by an issue of new Ordinary Shares to existing and new investors to raise £1.25 million
Physiomics* (LON:PYC) 2.75p £1.98m
Physiomics PLC, a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that, based on its unaudited management accounts for the year ended 30 June 2019, the Company is trading in line with analyst expectations.
Total income (revenue and grant income) increased 53% to £783,101 (2018: £512,899)
The operating loss decreased 23% to £201,219 (2018 £260,391)
The loss after taxation decreased 43% to £104,040 (2018: £183,341)
Operational:
Agreements signed with Merck KGaA for £435,000 for consulting services in calendar year 2019
Addition of two new biotech clients, Convert Pharmaceuticals (Belgium) and Bicycle Therapeutics (UK)
Attendance at major conferences including EORTC-NCI-AACR (Dublin), Biotech Showcase (San Francisco), AACR (Atlanta), BioTrinity (London) and PAGE (Stockholm)
Presentation of posters at both the AACR and PAGE conferences
Signing of a strategic collaboration with the Medicines Discovery Catapult (Alderley Park, UK)
IQE (LON:IQE) 65.4p £518m
IQE, the leading global supplier of advanced wafer products and materials solutions to the semiconductor industry, announces the successful device and module qualification for VCSEL epi-wafers for a major Asian OEM. This represents an important development in the adoption of 3D sensing technology by Android smartphones, with production volumes anticipated in 2020.
Vertical Cavity Surface Emitting Lasers (VCSELs) are a key component in multiple current and future 3D sensor systems, using both structured light and Time of Flight (ToF) technologies. Applications range from 3D Facial Identification (front facing) systems and world facing cameras on mobile handsets, to LiDAR and in cabin sensing for autonomous drive vehicles.
Production volumes are expected to ramp strongly over the next few years as adoption across multiple mobile platforms and other use cases proliferate. In anticipation of this strong growth, IQE has invested over the last two years in building the worlds' largest VCSEL epi-wafer facility in Newport, UK (IQE's Mega Epi Foundry).
Thor Mining* (LON:THR) 0.44p £4.5m
The Board of Thor Mining advises publication of a maiden Mineral Resource Estimate for the Big Sandy Lithium Deposit in Arizona, USA, by Hawkstone Mining Limited ("Hawkstone") (ASX: HWK).
Hawkstone, the 100% owner of the Big Sandy project, has announced an Indicated and Inferred Mineral Resource Estimate of 32.5m Tonnes grading 1,850 parts per million (ppm) Li, or 320,800 tonnes Lithium Carbonate Equivalent, reported above an 800ppm Li cut-off.
Concepta* (LON:CPT) 1.65p £4.4m
Concepta, the innovative UK personalised healthcare company and developer of the proprietary self-test platform ("myLotus®"), the most accurate home-use fertility tracking and pregnancy testing system available on the U.K. market, announces today encouraging interim results, showing initial sales and scale up of its proprietary self-test platform, myLotus®, an improved cash position and a narrower loss for the period.
Further to Concepta’s interim results statement, we highlight a second positive announcement, in which it announces its first UK Fertility Clinic collaboration with
Solid State PLC (LON:SOLI) 497.2p £42.3m
Solid State, the AIM listed manufacturer of computing, power and communications products, and value added distributor of electronic components, announced an international contract win.
The contract, valued at $3m, has been won by the Group's Pacer Optoelectronics business unit, acquired by Solid State in November 2018. The display project, a rail infrastructure programme in the United States, will utilise Pacer's value added capabilities and is expected to be delivered over the next nine months.
Savannah Resources (LON:SAV) 2.15p £28m
Savannah Resources, the AIM quoted resource development company, announces that further to the recent placing and subscription to raise £3.76m(before expenses), as announced on 16 September 2019, Al Marjan Ltd, the Company's largest shareholder, has now subscribed for 60,000,000 new ordinary shares of 1p each in the Company ('Ordinary Shares') at a price of 2p per Ordinary Share, along with other subscribers raising cash proceeds of £1.24 million
Amryt Pharma PLC (LON:AMYT) 133p £372m
Amryt Pharma put out an RNS today about their IR programme, a fairly long list of making the most of being listed and pretty impressive, meetings such as; Cantor Fitzgerald Global Healthcare Conference, New York, NY. Various Shares Magazine Investor Evenings, 2 x Proactive Investors One2One Investor Forums, Stifel Healthcare Conference, New York, NY and Jefferies Global Healthcare Conference, London, UK.
Seeing Machines Ltd (LON:SEE) 4.5p £151m
Seeing Machines Limited the leading provider of AI-enabled driver monitoring technology for improved transport safety, advises that the Board has invited Paul McGlone, CEO, to participate in the Seeing Machines Employee Benefits Plan and has awarded rights in respect of a total of 37,000,000 ordinary shares of no par value in the Company ("Ordinary Shares") .